Section 1: The Inevitable Cliff and the Valley of Opportunity In the high-stakes world of pharmaceuticals, there is no force […]
Turning Pharmaceutical Patent Expirations into Competitive Advantage Read Post »
Executive Summary The global generic drug market stands at a strategic inflection point, poised for robust expansion while simultaneously confronting
Executive Summary Risk Evaluation and Mitigation Strategies (REMS) are critical drug safety programs mandated by the U.S. Food and Drug
Breaking the REMS Barrier: The Fight for Fair Drug Competition Read Post »
The $2 Billion Problem and the AI Promise Welcome to the paradoxical world of modern pharmaceutical research and development. It
How Machine Learning is Recoding the Future of Drug Discovery Read Post »
Executive Summary This report provides a comprehensive strategic framework for succeeding in the global generic drug market, a sector defined
Executive Summary The global generic drug market is at a strategic inflection point. While propelled by powerful, non-cyclical tailwinds such
In pharmaceutical regulation, few programs embody a more profound paradox than the U.S. Food and Drug Administration’s (FDA) Risk Evaluation
REMS: The Regulatory Shield Blocking Affordable Generics Read Post »
Executive Summary The escalating cost of prescription drugs in the United States has prompted a significant shift in the Food
The ‘Rule of Three’: How the FDA is Hacking Drug Prices Read Post »
Executive Summary Generic drugs are foundational to global healthcare systems, providing essential, affordable medication to a vast patient population. In
Optimizing Partnerships for Generic Drug Development Success Read Post »
Get fresh news and insights, drug patent expirations & more…
